放射肿瘤学市场规模、份额和成长分析（按系统和软体、技术、应用、治疗方法和地区划分）—2026-2033年产业预测

预计到 2024 年，全球放射治疗市场规模将达到 75.9 亿美元，到 2025 年将达到 79.5 亿美元，到 2033 年将达到 114.8 亿美元，预测期（2026-2033 年）的复合年增长率为 4.7%。

受癌症发病率上升和对有效治疗方法需求不断增长的推动，全球放射治疗市场正经历显着增长。随着人口老化，罹患各种癌症的风险增加，人们对放射治疗益处的认识也不断提高，促使更多患者选择这种治疗方法。包括精准靶向照射和尖端成像技术在内的高科技放射治疗设备的进步，提高了治疗的有效性和安全性，吸引了患者和医疗服务提供者的注意。然而，挑战仍然存在，例如缺乏掌握先进放射技术和复杂肿瘤可视化技术的合格人员，这可能会阻碍治疗计划的製定。同时，新兴市场医疗基础设施的改善和癌症治疗覆盖范围的扩大，为市场带来了巨大的成长机会。

全球放射治疗市场驱动因素

全球放射治疗市场的成长主要受全球癌症发生率上升的推动。人口老化、生活方式的改变以及环境毒素暴露的增加是导致这一增长的主要因素。随着癌症诊断数量的增加，对放射治疗等有效治疗方法的需求日益增长，这对于控制各种类型的癌症至关重要。此外，人们对早期诊断和及时治疗重要性的认识不断提高，预计将进一步增加对放射治疗服务的需求，从而满足这些紧迫的医疗需求，并最终推动市场扩张。

限制全球放射治疗市场的因素

全球放射肿瘤市场面临严峻挑战，主要原因是高昂的成本限制了患者获得必要的放射治疗，尤其是中低收入国家。设备和治疗费用高昂，阻碍了医疗机构投资先进技术。因此，经济困难的患者往往难以获得这项关键治疗。这种情况造成了放射治疗机会的巨大差异，尤其是在资源匮乏的地区。这反过来又阻碍了整个放射肿瘤市场的成长，并影响了患者在最需要的时候获得关键癌症治疗的能力。

全球放射治疗市场趋势

全球放射治疗市场正经历着向个人化医疗的显着转变，这正在改变放射线治疗的研发和实施方式。基因和分子分析技术的进步使医疗服务提供者能够根据每位患者独特的生物学特征量身定制放射治疗方案。这种个人化方法不仅提高了治疗效果，还最大限度地减少了副作用，最终实现了更精准的肿瘤标靶治疗和更佳的患者预后。随着个人化医疗研究的不断深入，治疗方法和策略也不断改进，放射治疗的未来正处于变革的边缘。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球放射肿瘤市场规模（按系统和软体划分）及复合年增长率（2026-2033 年）

• 系统
• 软体和服务

全球放射肿瘤市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 体外放射治疗技术
  • 直线加速器
  • 传统直线加速器
  • 用于立体定位治疗的先进电子束/钴-60直线加速器
  • 磁共振直线加速器
  • 粒子束疗法
  • 迴旋加速器
  • 同步辐射
  • 同步迴旋加速器
  • 常规钴-60外照射放射治疗
• 体内放射治疗/近距离放射治疗
  • 种子
  • 后荷机
  • IORT系统
  • 涂抹器

全球放射肿瘤市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 体外放射治疗的适应症
  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 头颈癌
  • 大肠直肠癌
  • 其他体外放射治疗应用
• 内放射治疗/近距离放射治疗的适应症
  • 摄护腺癌
  • 妇科癌症
  • 乳癌
  • 子宫颈癌
  • 阴茎癌
  • 内放射治疗/近距离放射治疗的其他适应症

全球放射肿瘤市场规模（按治疗方法类型和复合年增长率划分）（2026-2033 年）

• 体外放射治疗
  • 影像导航放射治疗
  • 强度调控放射治疗
  • 3D适形放射治疗
  • 立体定位放射治疗
  • 粒子束疗法
  • 其他体外放射治疗技术
• 内照射放射线治疗/近距离放射治疗
  • 低剂量率（LDR）近距离放射
  • 高剂量率近距离近距离放射
  • PDR近距离放射治疗

全球放射肿瘤市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Accuray Incorporated（USA）
• Elekta AB（Sweden）
• IBA（Ion Beam Applications SA）（Belgium）
• Isoray Medical Inc.（USA）
• Eckert & Ziegler Group（Germany）
• Nordion Inc.（Canada）
• Mevion Medical Systems（USA）
• Hitachi, Ltd.（Japan）
• ViewRay Technologies, Inc.（USA）
• Panacea Medical Technologies Pvt. Ltd.（India）
• Canon Medical Systems Corporation（Japan）
• RaySearch Laboratories（Sweden）
• Mitsubishi Electric Corporation（Japan）
• NTP Radioisotopes SOC Ltd.（South Africa）
• RefleXion（USA）
• Toshiba Energy Systems & Solutions Corporation（Japan）
• P-Cure Ltd.（Israel）
• Provision Healthcare（USA）
• Brainlab AG（Germany）

结论与建议

Global Radiotherapy Market size was valued at USD 7.59 Billion in 2024 and is poised to grow from USD 7.95 Billion in 2025 to USD 11.48 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global radiotherapy market is witnessing substantial growth driven by the rising incidence of cancer and an increasing demand for effective treatment options. As the aging population becomes more susceptible to various cancers, there is heightened awareness of the benefits of radiotherapy, encouraging more patients to seek this form of treatment. Advances in high-tech radiotherapy devices, including precision targeting and cutting-edge imaging technologies, have enhanced treatment efficacy and safety, drawing interest from both patients and healthcare providers. Nonetheless, challenges persist due to a shortage of qualified professionals trained in advanced radiation techniques and complexities related to tumor visualization that can hinder treatment planning. Conversely, emerging markets present significant opportunities for growth as healthcare infrastructure improves and access to cancer treatments expands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiotherapy Market Segments Analysis

Global Radiotherapy Market is segmented by System And Software, Technology, Application, Procedure and region. Based on System And Software, the market is segmented into Systems and Software & Services. Based on Technology, the market is segmented into External Beam Radiotherapy Technologies and Internal Beam Radiotherapy/Brachytherapy. Based on Application, the market is segmented into External Beam Radiotherapy Applications and Internal Beam Radiotherapy/Brachytherapy Applications. Based on Procedure, the market is segmented into External Beam Radiotherapy and Internal Beam Radiotherapy/Brachytherapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Radiotherapy Market

The global radiotherapy market is significantly driven by the escalating incidence of cancer worldwide. Several key factors contribute to this rise, including an aging population, shifts in lifestyle choices, and heightened exposure to environmental toxins. As the number of cancer diagnoses grows, the demand for effective treatment options like radiation therapy becomes increasingly critical for managing various types of cancer. Additionally, growing awareness surrounding the importance of early diagnosis and timely treatment is expected to further elevate the necessity for radiotherapy services, ultimately propelling the market's expansion in response to these pressing healthcare needs.

Restraints in the Global Radiotherapy Market

The global radiotherapy market faces considerable challenges due to significant cost barriers that restrict access to essential radiation treatments, particularly in low- and middle-income countries. The high expenses associated with both equipment and procedures deter healthcare institutions from investing in advanced technology. Consequently, patients experiencing financial difficulties often struggle to afford these critical treatments. This situation creates a substantial gap in access to radiotherapy, especially in areas where healthcare resources are limited. As a result, the overall growth of the radiotherapy market is impeded, impacting patients' ability to receive vital cancer care when needed most.

Market Trends of the Global Radiotherapy Market

The Global Radiotherapy market is experiencing a significant trend towards personalized healthcare, marking a shift in how radiation therapies are developed and administered. As advancements in genetic and molecular profiling emerge, healthcare providers are increasingly able to customize radiation treatment regimens to align with each patient's unique biological characteristics. This tailored approach not only enhances the effectiveness of treatments but also minimizes side effects, ultimately leading to improved tumor targeting and better patient outcomes. The future of radiotherapy is poised for transformation, driven by ongoing research in personalized medicine, which will further refine treatment modalities and approaches.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Radiotherapy Market Size by System And Software & Service & CAGR (2026-2033)

• Market Overview
• Systems
• Software & Services

Global Radiotherapy Market Size by Technology & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy Technologies
  • Linacs
  • Conventional Linacs
  • Stereotactic Advanced Electron/Cobalt-60 Linacs
  • Mri Linacs
  • Particle Therapy
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
  • Conventional Cobalt-60 Teletherapy
• Internal Beam Radiotherapy/Brachytherapy
  • Seeds
  • Afterloaders
  • IORT Systems
  • Applicators

Global Radiotherapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy Applications
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Other External Beam Radiotherapy Applications
• Internal Beam Radiotherapy/Brachytherapy Applications
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Cervical Cancer
  • Penile Cancer
  • Other Internal Beam Radiotherapy/Brachytherapy Applications

Global Radiotherapy Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy
  • Image-Guided Radiotherapy
  • Intensity-Modulated Radiotherapy
  • 3d Conformal Radiotherapy
  • Stereotactic Radiotherapy
  • Particle Therapy
  • Other External Beam Radiotherapy Procedures
• Internal Beam Radiotherapy/Brachytherapy
  • LDR Brachytherapy
  • HDR Brachytherapy
  • PDR Brachytherapy

Global Radiotherapy Market Size & CAGR (2026-2033)

• North America (System And Software & Service, Technology, Application, Procedure)
  • US
  • Canada
• Europe (System And Software & Service, Technology, Application, Procedure)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System And Software & Service, Technology, Application, Procedure)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System And Software & Service, Technology, Application, Procedure)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System And Software & Service, Technology, Application, Procedure)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Ion Beam Applications SA) (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mevion Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Electric Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NTP Radioisotopes SOC Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RefleXion (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Energy Systems & Solutions Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P-Cure Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Provision Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations